From April 28, 2023 to June 30, 2023, the company has repurchased 421,100 shares, representing 0.25% for CNY 5.07 million. With this, the company has completed the repurchase of 421,100 shares, representing 0.25% for CNY 5.07 million under the buyback announced on May 9, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9.91 CNY | -2.94% | -9.83% | -31.98% |
1st Jan change | Capi. | |
---|---|---|
-31.98% | 239M | |
+12.21% | 8.05B | |
+8.98% | 7.96B | |
+2.57% | 6.12B | |
-5.61% | 3.73B | |
-12.74% | 3.51B | |
-16.29% | 1.19B | |
-25.82% | 1.12B | |
+10.93% | 975M | |
-14.72% | 828M |
- Stock Market
- Equities
- 603079 Stock
- News Zhejiang Shengda Bio-Pharm Co., Ltd.
- Tranche Update on Zhejiang Shengda Bio-Pharm Co., Ltd.'s Equity Buyback Plan announced on May 9, 2023.